RecruitingNCT03300830

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease


Sponsor

National Cancer Institute (NCI)

Enrollment

280 participants

Start Date

Dec 20, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Background: A person s genome is the collection of all their genes. A gene instructs individual cells to make proteins. Proteins are involved in all of our body s chemical processes. Genome sequencing allows researchers to find variations in genes. Some of these are normal and are not known to cause disease. Some variants are known to cause or affect diseases like cancer. Researchers want to study genetic variants in people with cancer who also have an immunologic disease like HIV. Objective: To study the biology of cancer in order to improve ways to prevent, detect, and treat it. Eligibility: Adults at least 18 years old with certain cancers and/or immunodeficiencies Design: Participants will be screened with medical history, physical exam, and lab tests. Participants will give samples of one or more tissue type. They may give blood or urine samples. Researchers may get samples of tissue when participants have surgery or when the participants are on other protocols in the NCI. Participants may have a procedure to have tissue samples removed. Researchers may collect data from participant medical records. Researchers will compare the genes in a participant s cancer tissue to their normal tissue. They may use the tissue cells to grow new cells in a lab. Participants may be contacted about the results. The samples will be stored for future research. No personal data will be kept with them. ...


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting samples and data from people who have cancers that are linked to viruses (like HPV or EBV), HIV-related cancers, or a rare condition called Castleman disease, to better understand how these cancers develop and find better treatments. **You may be eligible if...** - You have HIV or another immune deficiency and also have cancer - You have a cancer that is known or suspected to be caused by a virus - You have a cancer that commonly occurs in people with HIV, even if you are HIV-negative - You have Castleman disease - You are willing to share medical records and samples **You may NOT be eligible if...** - You are not willing or able to give informed consent - Your condition does not fall into the categories being studied Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03300830


Related Trials